---
title: "Hyphens Pharma Introduces Novel Acne Treatment in Singapore, Malaysia; Shares Up Nearly 2%"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/249080126.md"
description: "Hyphens Pharma , through Hyphens Pharma International, launched Winlevi (clascoterone) cream 1% in Singapore and Malaysia, according to a Thursday filing with the Singapore Exchange. Shares of the company were up nearly 2% in recent trading. The launch comes after the company entered into an exclusive license and supply agreement with Cosmo Pharmaceuticals subsidiary Cassiopea. The acne cream provides treatment for acne-related inflammation."
datetime: "2025-07-18T05:34:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/249080126.md)
  - [en](https://longbridge.com/en/news/249080126.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/249080126.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/249080126.md) | [English](https://longbridge.com/en/news/249080126.md)


# Hyphens Pharma Introduces Novel Acne Treatment in Singapore, Malaysia; Shares Up Nearly 2%

Hyphens Pharma , through Hyphens Pharma International, launched Winlevi (clascoterone) cream 1% in Singapore and Malaysia, according to a Thursday filing with the Singapore Exchange.

Shares of the company were up nearly 2% in recent trading.

The launch comes after the company entered into an exclusive license and supply agreement with Cosmo Pharmaceuticals subsidiary Cassiopea.

The acne cream provides treatment for acne-related inflammation.

### 相關股票

- [Hyphens Pharma (1J5.SG)](https://longbridge.com/zh-HK/quote/1J5.SG.md)

## 相關資訊與研究

- [Hyphens Pharma profit dives 44% in 2025 despite record 40.7% gross margins](https://longbridge.com/zh-HK/news/276821357.md)
- [IFW Dresden selects Agnitron Agilis 100 MOCVD platform for precursor chemistry and ultra-wide-bandgap materials development](https://longbridge.com/zh-HK/news/279074236.md)
- [ZAWYA-PROJECTS: Dubai's DP World sets 2026 capex budget at $3bn](https://longbridge.com/zh-HK/news/279073080.md)
- [Santander Discloses Senior Executive’s Sale of ADRs on NYSE](https://longbridge.com/zh-HK/news/279073285.md)
- [Dr. Reddy’s Flags Phase III Setback as Immutep Halts Key Lung Cancer Trial](https://longbridge.com/zh-HK/news/279076056.md)